Therefore, the binding of OPG to TRAIL prevents its action, deflecting the problem of the TRAIL-induced apoptosis of cancer cells due to the binding of TRAIL to membrane death receptors, such as death receptors 4 and 5 (DR4-DR5) [60,61]. Here, TNFRSF10A is linked to cancer.